Prostate News Archive
18-Apr-2009
Prostate Vaccine News "Reason For Optimism" (Medical News Today)
Below is a comment from Otis W. Brawley, M.D., American Cancer Society chief medical officer, on the announcement that the experimental vaccine Provenge increased survival in men with prostate cancer. "This announcement is reason for optimism about a vaccine that has generated controversy for several years. 9Health Fair helps men find life beyond prostate cancer (9 News Denver)
KUSA - The idea of a getting a test that could indicate prostate cancer is, for a lot of men, uncomfortable and embarrassing. Phase-3 IMPACT study of Provenge shows overall survival benefits in men with advanced prostate cancer (PharmaBiz)
Dendreon Corporation announced that the pivotal phase-3 IMPACT study of Provenge (sipuleucel-T) in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control. EAU Position Statement On Screening For Prostate Cancer (Medical News Today)
The European Association of Urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (Schroder et al, NEJM 2009).
Back to Prostate News Archive
